Literature DB >> 18294724

Actin cytoskeletal organisation in osteoclasts: a model to decipher transmigration and matrix degradation.

Frédéric Saltel1, Anne Chabadel, Edith Bonnelye, Pierre Jurdic.   

Abstract

Osteoclasts are large monocyte-derived multinucleated cells whose function is to resorb bone, i.e. a mineralised extracellular matrix. They exhibit two different actin cytoskeleton organisations according to their substratum. On non-mineralised substrates they form canonical podosomes, but on mineralised extracellular matrices they form a sealing zone. Podosomes consist of two functionally different actin subdomains: a podosome core, probably made of branched actin organised through a CD44 transmembrane receptor, and an actin cloud of actin cables organised around alphavbeta3 integrin. During osteoclast differentiation, podosome patterning is highly dynamic, and we propose that it ends up in a sealing zone in mature bone-resorbing osteoclasts after a complete reorganisation of the two subdomains. In addition to matrix degradation, osteoclasts share with tumour cells the ability to transmigrate through cell layers and-for that purpose-can arrange their cytoskeleton in long protrusions reminiscent of invadopodia. In this review, we discuss the relationships between podosomes and sealing zone, comparing their structures, their molecular composition and their abilities to degrade extracellular matrices. The dynamic actin remodelling in osteoclasts appears then as a major factor to understand their unusual abilities reminiscent of metastatic tumour cells.

Entities:  

Mesh:

Year:  2008        PMID: 18294724     DOI: 10.1016/j.ejcb.2008.01.001

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  69 in total

1.  Rac deletion in osteoclasts causes severe osteopetrosis.

Authors:  Monica Croke; F Patrick Ross; Matti Korhonen; David A Williams; Wei Zou; Steven L Teitelbaum
Journal:  J Cell Sci       Date:  2011-11-23       Impact factor: 5.285

2.  Cytoskeletal dysfunction dominates in DAP12-deficient osteoclasts.

Authors:  Wei Zou; Tingting Zhu; Clarissa S Craft; Thomas J Broekelmann; Robert P Mecham; Steven L Teitelbaum
Journal:  J Cell Sci       Date:  2010-09-01       Impact factor: 5.285

3.  Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization.

Authors:  Yuji Ito; Steven L Teitelbaum; Wei Zou; Yi Zheng; James F Johnson; Jean Chappel; F Patrick Ross; Haibo Zhao
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

4.  Protein tyrosine phosphatase epsilon regulates integrin-mediated podosome stability in osteoclasts by activating Src.

Authors:  Shira Granot-Attas; Chen Luxenburg; Eynat Finkelshtein; Ari Elson
Journal:  Mol Biol Cell       Date:  2009-08-19       Impact factor: 4.138

Review 5.  Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions.

Authors:  Corinne Albiges-Rizo; Olivier Destaing; Bertrand Fourcade; Emmanuelle Planus; Marc R Block
Journal:  J Cell Sci       Date:  2009-09-01       Impact factor: 5.285

6.  Three-dimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysis.

Authors:  Céline Cougoule; Véronique Le Cabec; Renaud Poincloux; Talal Al Saati; Jean-Louis Mège; Guillaume Tabouret; Clifford A Lowell; Nathalie Laviolette-Malirat; Isabelle Maridonneau-Parini
Journal:  Blood       Date:  2009-11-06       Impact factor: 22.113

7.  Zap70 inhibits Syk-mediated osteoclast function.

Authors:  Wei Zou; Monica Croke; Tomohiro Fukunaga; Thomas J Broekelmann; Robert P Mecham; Steven L Teitelbaum
Journal:  J Cell Biochem       Date:  2013-08       Impact factor: 4.429

Review 8.  Osteoclast motility: putting the brakes on bone resorption.

Authors:  Deborah V Novack; Roberta Faccio
Journal:  Ageing Res Rev       Date:  2009-09-27       Impact factor: 10.895

9.  Bone is not essential for osteoclast activation.

Authors:  Karen Fuller; Jade L Ross; Kinga A Szewczyk; Raymond Moss; Tim J Chambers
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

10.  Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo.

Authors:  You Me Sung; Xuehua Xu; Junfeng Sun; Duane Mueller; Kinza Sentissi; Peter Johnson; Elana Urbach; Françoise Seillier-Moiseiwitsch; Michael D Johnson; Susette C Mueller
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.